Member Info for BertieBassett

http://files.imagingbiometrics.com/v/ncRczEChiDbV3VxXGzqfm9nsw

Quite powerful stuff from Imaging Biometrics

-- BB --

very interesting - especially the companies that hold the most FDA authorisations - GE, Siemens, Canon, Aidoc and Philips. All multi-billion dollar companies in the medical AI space ...
-- BB --

I am with you ... am on the same journey!
hope to despair, hope to despair ...
I do believe in the tech ... and the applications will be groundbreaking ... if they ever get more widely used.
Need some news from the FDA - as a start ... well, actually just some news would be good.
I am heartened by the Tweets - in that IQAI is still being talked about.
Hopefully there is much going on behind closed doors ... but will an sp like we have now, I am not holding my breath ... huff ...
-- BB --

eek!
-- BB --

there already is a US listing!
OTCQB:IQAIF
-- BB --

https://www.lse.co.uk/rns/IQAI/directors-interest-99rxup1l39r4a15.html - from December 2021. He relinquished his place at the company ... AND a quick check on companies house and Trevor is not there anymore ... but his son his-... ! Just joining dots ... !
-- BB --

Um - I think he passed those shares to his son?
-- BB --

https://twitter.com/IQAI_IB/status/1569714271226839042
Dr. Jennifer Connelly, Prof of Neurology at MCW and PI of @IQAI_IB's sponsored trial, today presented “Disappearing Spoon, Disappearing Cancer and the link to heavy metals” at the Northshore Neurologic Institute (Chicago) and was named the Gore Lecturer of the Year!
-- BB --

Not at all Drax ... when investors complain that there is not enough interaction ... we get some ... and then ... complaints ... so IQ-AI can't win. I like to know what's going on ... and every little bit helps ... :)
-- BB --

https://twitter.com/IQAI_IB/status/1569449923799830528/photo/1
re: The inherent value of Standardization in IB Neuro!

-- BB --

Today, an estimated 700,000 people in the United States are living with a primary brain tumour, and approximately 88,970 more will be diagnosed in 2022. More than 11,000 people are diagnosed with a primary brain tumour in the UK each year, of which about half are cancerous.
https://twitter.com/IQAI_IB/status/1568282552548433920
https://virtualtrials.org/newsarticle.cfm?item=7314
-- BB --

https://twitter.com/IQAI_IB/status/1567571772815327234

"At the same time GBM patients inquire about the Ph I clinical trial, they also inquire about @IQAI_IB's quantitative imaging software being used to monitor response. Several want their MRI exams analyzed with IB Software now! @gbmfoundation @EndBrainCancer @AlMusella @theABTA"
-- BB --

Stay positive Trek.
While the SP wiggles and the journey is a wee bumpy, there are very bright flashes from the "real world"!
"I am a participant in this trial. It has been a very positive experience so far."
-- BB --

Hi,
Does anyone have a link on the FDA site for the IB Zero G software submission by Imaging Biometrics please?
Can't seem to find one.
Thank you, in advance,
-- BB --

IQAI is main market, not AIM
-- BB --

Outlook: The development of both NIMBLE and the service model offer the prospect of new income streams in the months ahead which could complement our ongoing development projects discussed above.
-- BB --

Um - you may find that he cannot buy any more as it will take him over the 30% mark ... I think I am right there ... ?
Also, he could have offloaded everything at 21 pps ... but he didn't ...
-- BB --

would be interesting to know when Eko submitted its FDA approval application ... would give us a better steer on when IQAI decision can be expected ...
-- BB --

Wow! Another huge drop on just a few trades ...
TB may as well go private at this SP!
-- BB --

https://twitter.com/Blackford/status/1539958510296780800?t=H2OwrRmn8Dz43R7Hc0kIjQ&s=09
-- BB --